BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: O'Connor A, O'Morain CA, Ford AC. Population screening and treatment of Helicobacter pylori infection. Nat Rev Gastroenterol Hepatol. 2017;14:230-240. [PMID: 28053340 DOI: 10.1038/nrgastro.2016.195] [Cited by in Crossref: 94] [Cited by in F6Publishing: 83] [Article Influence: 18.8] [Reference Citation Analysis]
Number Citing Articles
1 Kumari R, Sunil D. Emerging trends in aggregation induced emissive luminogens as bacterial theranostics. J Drug Target 2021;29:793-807. [PMID: 33583291 DOI: 10.1080/1061186X.2021.1888111] [Reference Citation Analysis]
2 Liou JM, Chen CC, Chang CM, Fang YJ, Bair MJ, Chen PY, Chang CY, Hsu YC, Chen MJ, Lee JY, Yang TH, Luo JC, Chen CY, Hsu WF, Chen YN, Wu JY, Lin JT, Lu TP, Chuang EY, El-Omar EM, Wu MS;  Taiwan Gastrointestinal Disease and Helicobacter Consortium. Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial. Lancet Infect Dis. 2019;19:1109-1120. [PMID: 31559966 DOI: 10.1016/s1473-3099(19)30272-5] [Cited by in Crossref: 43] [Cited by in F6Publishing: 23] [Article Influence: 21.5] [Reference Citation Analysis]
3 Zhong MF, Li J, Liu XL, Gong P, Zhang XT. TCM-Based Therapy as a Rescue Therapy for Re-Eradication of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med 2022;2022:5626235. [PMID: 35251209 DOI: 10.1155/2022/5626235] [Reference Citation Analysis]
4 Li XY, Shi LX, Yao XM, Jing M, Li QQ, Wang YL, Li QS. Functional vinorelbine plus schisandrin B liposomes destroying tumor metastasis in treatment of gastric cancer. Drug Dev Ind Pharm 2021;47:100-12. [PMID: 33295825 DOI: 10.1080/03639045.2020.1862169] [Reference Citation Analysis]
5 Ge Z, Ge L, Muthupalani S, Feng Y, Fox JG. Male-Dependent Promotion of Colitis in 129 Rag2-/- Mice Co-Infected with Helicobacter pylori and Helicobacter hepaticus. Int J Mol Sci 2020;21:E8886. [PMID: 33255175 DOI: 10.3390/ijms21238886] [Reference Citation Analysis]
6 Boyanova L, Gergova G, Markovska R, Kandilarov N, Davidkov L, Spassova Z, Mitov I. Primary Helicobacter pylori resistance in elderly patients over 20 years: A Bulgarian study. Diagn Microbiol Infect Dis. 2017;88:264-267. [PMID: 28506722 DOI: 10.1016/j.diagmicrobio.2017.05.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
7 Lin Y, Kawai S, Sasakabe T, Nagata C, Naito M, Tanaka K, Sugawara Y, Mizoue T, Sawada N, Matsuo K, Kitamura T, Utada M, Ito H, Shimazu T, Kikuchi S, Inoue M; Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan. Effects of Helicobacter pylori eradication on gastric cancer incidence in the Japanese population: a systematic evidence review. Jpn J Clin Oncol 2021;51:1158-70. [PMID: 33893508 DOI: 10.1093/jjco/hyab055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Usui G, Shinozaki T, Jinno T, Fujibayashi K, Morikawa T, Gunji T, Matsuhashi N. Relationship between time-varying status of reflux esophagitis and Helicobacter pylori and progression to long-segment Barrett's esophagus: time-dependent Cox proportional-hazards analysis. BMC Gastroenterol 2020;20:270. [PMID: 32799812 DOI: 10.1186/s12876-020-01418-5] [Reference Citation Analysis]
9 Zhu L, Zhu JS, Lei SY, Gao CY, Li YH. Epidemiological analysis of upper gastrointestinal diseases in people of China's ethnic minorities in Menghai County. Shijie Huaren Xiaohua Zazhi 2018; 26(6): 394-400 [DOI: 10.11569/wcjd.v26.i6.394] [Reference Citation Analysis]
10 Guo Z, Tian S, Wang W, Zhang Y, Li J, Lin R. Correlation Analysis Among Genotype Resistance, Phenotype Resistance, and Eradication Effect After Resistance-Guided Quadruple Therapies in Refractory Helicobacter pylori Infections. Front Microbiol 2022;13:861626. [PMID: 35330762 DOI: 10.3389/fmicb.2022.861626] [Reference Citation Analysis]
11 Long X, Chen Q, Yu L, Liang X, Liu W, Lu H. Bismuth improves efficacy of proton-pump inhibitor clarithromycin, metronidazole triple Helicobacter pylori therapy despite a high prevalence of antimicrobial resistance. Helicobacter 2018;23:e12485. [DOI: 10.1111/hel.12485] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
12 Zhao L, Hu H, Gustafsson JÅ, Zhou S. Nuclear Receptors in Cancer Inflammation and Immunity. Trends Immunol 2020;41:172-85. [PMID: 31982345 DOI: 10.1016/j.it.2019.12.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Man SM. Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis. Nat Rev Gastroenterol Hepatol 2018;15:721-37. [PMID: 30185915 DOI: 10.1038/s41575-018-0054-1] [Cited by in Crossref: 104] [Cited by in F6Publishing: 91] [Article Influence: 34.7] [Reference Citation Analysis]
14 Chen X, Chen W, Zhao Y, Wang Q, Wang W, Xiang Y, Yuan H, Xie Y, Zhou J. Interplay of Helicobacter pylori, fibroblasts, and cancer cells induces fibroblast activation and serpin E1 expression by cancer cells to promote gastric tumorigenesis. J Transl Med 2022;20:322. [PMID: 35864535 DOI: 10.1186/s12967-022-03537-x] [Reference Citation Analysis]
15 Chen S, Ni Y, Liu S. Potential Association of IL1B Polymorphism With Iron Deficiency Risk in Childhood Helicobacter pylori Infection. Journal of Pediatric Gastroenterology & Nutrition 2018;66:e36-40. [DOI: 10.1097/mpg.0000000000001687] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
16 Banks M, Graham D, Jansen M, Gotoda T, Coda S, di Pietro M, Uedo N, Bhandari P, Pritchard DM, Kuipers EJ, Rodriguez-Justo M, Novelli MR, Ragunath K, Shepherd N, Dinis-Ribeiro M. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut 2019;68:1545-75. [PMID: 31278206 DOI: 10.1136/gutjnl-2018-318126] [Cited by in Crossref: 170] [Cited by in F6Publishing: 142] [Article Influence: 56.7] [Reference Citation Analysis]
17 Mannion A, Dzink-Fox J, Shen Z, Piazuelo MB, Wilson KT, Correa P, Peek RM Jr, Camargo MC, Fox JG. Helicobacter pylori Antimicrobial Resistance and Gene Variants in High- and Low-Gastric-Cancer-Risk Populations. J Clin Microbiol 2021;59:e03203-20. [PMID: 33692136 DOI: 10.1128/JCM.03203-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Chen ST, Ni YH, Li CC, Liu SH. Hepcidin correlates with interleukin-1β and interleukin-6 but not iron deficiency in children with Helicobacter pylori infection. Pediatr Neonatol 2018;59:611-7. [PMID: 29548703 DOI: 10.1016/j.pedneo.2018.02.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
19 Angsantikul P, Thamphiwatana S, Zhang Q, Spiekermann K, Zhuang J, Fang RH, Gao W, Obonyo M, Zhang L. Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against Helicobacter pylori infection. Adv Ther (Weinh) 2018;1:1800016. [PMID: 30320205 DOI: 10.1002/adtp.201800016] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 9.3] [Reference Citation Analysis]
20 Alpízar-Alpízar W, Skindersoe ME, Rasmussen L, Kriegbaum MC, Christensen IJ, Lund IK, Illemann M, Laerum OD, Krogfelt KA, Andersen LP, Ploug M. Helicobacter pylori Colonization Drives Urokinase Receptor (uPAR) Expression in Murine Gastric Epithelium During Early Pathogenesis. Microorganisms 2020;8:E1019. [PMID: 32660136 DOI: 10.3390/microorganisms8071019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Xu Y, Zhang P, Zhang K, Huang C. The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer. Biochim Biophys Acta Rev Cancer 2021;1876:188634. [PMID: 34656687 DOI: 10.1016/j.bbcan.2021.188634] [Reference Citation Analysis]
22 Asgari B, Kermanian F, Hedayat Yaghoobi M, Vaezi A, Soleimanifar F, Yaslianifard S. The Anti-Helicobacter pylori Effects of Lactobacillus acidophilus, L. plantarum, and L. rhamnosus in Stomach Tissue of C57BL/6 Mice. Visc Med 2020;36:137-43. [PMID: 32356850 DOI: 10.1159/000500616] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
23 Pasala C, Katari SK, Nalamolu RM, Bitla AR, Amineni U. Hierarchical-Clustering, Scaffold-Mining Exercises and Dynamics Simulations for Effectual Inhibitors Against Lipid-A Biosynthesis of Helicobacter pylori. Cell Mol Bioeng 2019;12:255-74. [PMID: 31719913 DOI: 10.1007/s12195-019-00572-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
24 Saito S, Azumi M, Muneoka Y, Nishino K, Ishikawa T, Sato Y, Terai S, Akazawa K. Cost-effectiveness of combined serum anti-Helicobacter pylori IgG antibody and serum pepsinogen concentrations for screening for gastric cancer risk in Japan. Eur J Health Econ 2018;19:545-55. [DOI: 10.1007/s10198-017-0901-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
25 Pasala C, Chilamakuri CSR, Katari SK, Nalamolu RM, Bitla AR, Amineni U. Epitope-driven common subunit vaccine design against H. pylori strains. Journal of Biomolecular Structure and Dynamics 2019;37:3740-50. [DOI: 10.1080/07391102.2018.1526714] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
26 Yang Y, Yang Y, Yuan Y, Zheng J, Zhongxi Z. Detecting helicobacter pylori in whole slide images via weakly supervised multi-task learning. Multimed Tools Appl 2020;79:26787-815. [DOI: 10.1007/s11042-020-09185-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
27 Alberts CJ, Jeske R, de Martel C, den Hollander WJ, Michel A, Prins M, Snijder MB, Schim van der Loeff MF, Waterboer T. Helicobacter pylori seroprevalence in six different ethnic groups living in Amsterdam: The HELIUS study. Helicobacter 2020;25:e12687. [PMID: 32147867 DOI: 10.1111/hel.12687] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
28 Stenger Moura FC, Cechinel-Filho V, Greco FA, Venzon L, Meurer MC, França TCDS, Longo B, Somensi LB, Mariano LNB, Cruz AB, Macchiarulo A, Schoubben A, Ricci M, Belle Bresolin TM, da Silva LM. Taxifolin and gastro-adhesive microparticles containing taxifolin promotes gastric healing in vivo, inhibits Helicobacter pylori in vitro and proton pump reversibly in silico. Chem Biol Interact 2021;339:109445. [PMID: 33741339 DOI: 10.1016/j.cbi.2021.109445] [Reference Citation Analysis]
29 Ranjbar R, Chehelgerdi M. Genotyping and antibiotic resistance properties of Helicobacter pylori strains isolated from human and animal gastric biopsies. Infect Drug Resist. 2018;11:2545-2554. [PMID: 30588039 DOI: 10.2147/idr.s187885] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
30 El-assaad F, Gong L, Gia A, Yim HCH, El-omar EM. Helicobacter pylori, Peptic Ulcer Disease and Gastric Cancer. Gastrointestinal Diseases and their Associated Infections. Elsevier; 2019. pp. 17-29. [DOI: 10.1016/b978-0-323-54843-4.00002-7] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
31 Varga MG, Wood CR, Butt J, Ryan ME, You WC, Pan K, Waterboer T, Epplein M, Shaffer CL. Immunostimulatory membrane proteins potentiate H. pylori-induced carcinogenesis by enabling CagA translocation. Gut Microbes 2021;13:1-13. [PMID: 33382363 DOI: 10.1080/19490976.2020.1862613] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
32 Chen B, Cai T, Huang C, Zang X, Sun L, Guo S, Wang Q, Chen Z, Zhao Y, Han Z, Xu R, Xu W, Wang M, Shen B, Zhu W. G6PD-NF-κB-HGF Signal in Gastric Cancer-Associated Mesenchymal Stem Cells Promotes the Proliferation and Metastasis of Gastric Cancer Cells by Upregulating the Expression of HK2. Front Oncol 2021;11:648706. [PMID: 33718248 DOI: 10.3389/fonc.2021.648706] [Reference Citation Analysis]
33 Li J, Wu G, Fu Q, Ge H, Liu S, Li X, Cheng B. Exploring the influence of conserved lysine69 on the catalytic activity of the helicobacter pylori shikimate dehydrogenase: A combined QM/MM and MD simulations. Computational Biology and Chemistry 2019;83:107098. [DOI: 10.1016/j.compbiolchem.2019.107098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Cherkas A, Zarkovic K, Cipak Gasparovic A, Jaganjac M, Milkovic L, Abrahamovych O, Yatskevych O, Waeg G, Yelisyeyeva O, Zarkovic N. Amaranth oil reduces accumulation of 4-hydroxynonenal-histidine adducts in gastric mucosa and improves heart rate variability in duodenal peptic ulcer patients undergoing Helicobacter pylori eradication. Free Radic Res 2018;52:135-49. [PMID: 29251014 DOI: 10.1080/10715762.2017.1418981] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
35 Gong L, El-Omar EM. Application of molecular techniques in Helicobacter pylori detection: limitations and improvements. Helicobacter 2021;:e12841. [PMID: 34333819 DOI: 10.1111/hel.12841] [Reference Citation Analysis]
36 Yan X, Liu L, Li H, Qin H, Sun Z. Clinical significance of Fusobacterium nucleatum, epithelial-mesenchymal transition, and cancer stem cell markers in stage III/IV colorectal cancer patients. Onco Targets Ther 2017;10:5031-46. [PMID: 29081665 DOI: 10.2147/OTT.S145949] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 7.6] [Reference Citation Analysis]
37 Monster JL, Kemp LJS, Gloerich M, van der Post RS. Diffuse gastric cancer: Emerging mechanisms of tumor initiation and progression. Biochim Biophys Acta Rev Cancer 2022;:188719. [PMID: 35307354 DOI: 10.1016/j.bbcan.2022.188719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Okuda M, Lin Y, Wang C, Kakiuchi T, Kikuchi S. Metronidazole for Helicobacter pylori eradication therapy among children and adolescents in Japan: Overcoming controversies and concerns. Helicobacter. 2019;24:e12575. [PMID: 30873719 DOI: 10.1111/hel.12575] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
39 Caguazango JC. Ecological models of gastric microbiota dysbiosis: Helicobacter pylori and gastric carcinogenesis. Medicine in Microecology 2020;3:100010. [DOI: 10.1016/j.medmic.2020.100010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
40 Kong Q, Li Y, Li R, Li Z, Zheng X, Wang Z, Song K, Zhang X, Liu J, Han Z, Duan M, Ding Y, Zhang W, Lin M, Wang J, Wan M, Lin B, Wang S, Zuo X, Li Y. Low compliance to post-screening recommendations in a family-based Helicobacter pylori screening and treatment program: A prospective cohort study. Helicobacter 2022;:e12912. [PMID: 35816511 DOI: 10.1111/hel.12912] [Reference Citation Analysis]
41 Cherkas A, Zarkovic N. 4-Hydroxynonenal in Redox Homeostasis of Gastrointestinal Mucosa: Implications for the Stomach in Health and Diseases. Antioxidants (Basel) 2018;7:E118. [PMID: 30177630 DOI: 10.3390/antiox7090118] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
42 Flores-Treviño S, Mendoza-Olazarán S, Bocanegra-Ibarias P, Maldonado-Garza HJ, Garza-González E. Helicobacter pylori drug resistance: therapy changes and challenges. Expert Rev Gastroenterol Hepatol 2018;12:819-27. [PMID: 29976092 DOI: 10.1080/17474124.2018.1496017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
43 Li T, Shao W, Li S, Ma L, Zheng L, Shang W, Jia X, Sun P, Liang X, Jia J. H. pylori infection induced BMAL1 expression and rhythm disorder aggravate gastric inflammation. EBioMedicine 2019;39:301-14. [PMID: 30502053 DOI: 10.1016/j.ebiom.2018.11.043] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
44 Shichijo S, Nomura S, Aoyama K, Nishikawa Y, Miura M, Shinagawa T, Takiyama H, Tanimoto T, Ishihara S, Matsuo K, Tada T. Application of Convolutional Neural Networks in the Diagnosis of Helicobacter pylori Infection Based on Endoscopic Images. EBioMedicine 2017;25:106-11. [PMID: 29056541 DOI: 10.1016/j.ebiom.2017.10.014] [Cited by in Crossref: 119] [Cited by in F6Publishing: 94] [Article Influence: 23.8] [Reference Citation Analysis]
45 Wang Y, Tang J, Zhou S, Liang TT, Wang FF, Ning H. Effectiveness and Safety of Rifaximin-Containing Regimens for Helicobacter pylori Eradication: Systematic Review - Are They Potential Eradication Regimens? Infect Drug Resist 2022;15:3733-49. [PMID: 35859911 DOI: 10.2147/IDR.S371131] [Reference Citation Analysis]
46 Shichijo S, Endo Y, Aoyama K, Takeuchi Y, Ozawa T, Takiyama H, Matsuo K, Fujishiro M, Ishihara S, Ishihara R, Tada T. Application of convolutional neural networks for evaluating Helicobacter pylori infection status on the basis of endoscopic images. Scand J Gastroenterol. 2019;54:158-163. [PMID: 30879352 DOI: 10.1080/00365521.2019.1577486] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
47 Chen M, Chen J, Yang Y, Cheng L, Wu HT. Possible association between Helicobacter pylori infection and vocal fold leukoplakia. Head Neck 2018;40:1498-507. [PMID: 29509297 DOI: 10.1002/hed.25121] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
48 Zhang L, Hu W, Cho CH, Chan FK, Yu J, Fitzgerald JR, Cheung CK, Xiao ZG, Shen J, Li LF, Li MX, Wu JC, Ling TK, Chan JY, Ko H, Tse G, Ng SC, Yu S, Wang MH, Gin T, Ashktorab H, Smoot DT, Wong SH, Chan MT, Wu WK. Reduced lysosomal clearance of autophagosomes promotes survival and colonization of Helicobacter pylori. J Pathol 2018;244:432-44. [PMID: 29327342 DOI: 10.1002/path.5033] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
49 Wei W, Liu C, Yao R, Tan Q, Wang Q, Tian H. miR‑486‑5p suppresses gastric cancer cell growth and migration through downregulation of fibroblast growth factor 9. Mol Med Rep 2021;24:771. [PMID: 34490480 DOI: 10.3892/mmr.2021.12411] [Reference Citation Analysis]
50 Koletzko L, Macke L, Schulz C, Malfertheiner P. Helicobacter pylori eradication in dyspepsia: New evidence for symptomatic benefit. Best Pract Res Clin Gastroenterol 2019;40-41:101637. [PMID: 31594649 DOI: 10.1016/j.bpg.2019.101637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
51 Basu N, Ghosh R. Recent chemical syntheses of bacteria related oligosaccharides using modern expeditious approaches. Carbohydr Res 2021;507:108295. [PMID: 34271477 DOI: 10.1016/j.carres.2021.108295] [Reference Citation Analysis]
52 Figueroa-Protti L, Soto-Molinari R, Calderón-Osorno M, Mora J, Alpízar-Alpízar W. Gastric Cancer in the Era of Immune Checkpoint Blockade. J Oncol 2019;2019:1079710. [PMID: 31662748 DOI: 10.1155/2019/1079710] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
53 周林, 赵阳鹏, 张伟. 幽门螺杆菌根除治疗在胃癌预防中的现状及前景. 世界华人消化杂志 2017; 25(15): 1327-1337 [DOI: 10.11569/wcjd.v25.i15.1327] [Reference Citation Analysis]
54 Zuo ZT, Ma Y, Sun Y, Bai CQ, Ling CH, Yuan FL. The Protective Effects of Helicobacter pylori Infection on Allergic Asthma. Int Arch Allergy Immunol 2021;182:53-64. [PMID: 33080611 DOI: 10.1159/000508330] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
55 Wang Y, Wang B, Wu J, Jiang X, Tang H, Nielsen OH. Modulation of Gut Microbiota in Pathological States. Engineering 2017;3:83-9. [DOI: 10.1016/j.eng.2017.01.013] [Cited by in Crossref: 16] [Article Influence: 3.2] [Reference Citation Analysis]
56 Varga MG, Butt J, Blot WJ, Le Marchand L, Haiman CA, Chen Y, Wassertheil-Smoller S, Tinker LF, Peek RM Jr, Potter JD, Cover TL, Hyslop T, Zeleniuch-Jacquotte A, Berndt SI, Hildesheim A, Waterboer T, Pawlita M, Epplein M. Racial Differences in Helicobacter pylori CagA Sero-prevalence in a Consortium of Adult Cohorts in the United States. Cancer Epidemiol Biomarkers Prev 2020;29:2084-92. [PMID: 32856604 DOI: 10.1158/1055-9965.EPI-20-0525] [Reference Citation Analysis]
57 Wang J, Zhang Y, Zhu Y, Liu J, Chen Y, Cao X, Yang Y. Total Synthesis and Immunological Evaluation of the Tri- d - glycero - d - manno -heptose Antigen of the Lipopolysaccharide as a Vaccine Candidate against Helicobacter pylori. Org Lett 2020;22:8780-5. [DOI: 10.1021/acs.orglett.0c03105] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
58 Carlos ABM, de Oliveira CV, Rodrigues MAM, Costa VE. Is breath testing without 13C-labelled external urea able to detect Helicobacter pylori infection? Anal Bioanal Chem 2019;411:5641-5. [PMID: 31201459 DOI: 10.1007/s00216-019-01961-5] [Reference Citation Analysis]
59 Giaretta PR, Suchodolski JS, Jergens AE, Steiner JM, Lidbury JA, Cook AK, Hanifeh M, Spillmann T, Kilpinen S, Syrjä P, Rech RR. Bacterial Biogeography of the Colon in Dogs With Chronic Inflammatory Enteropathy. Vet Pathol 2020;57:258-65. [PMID: 31916499 DOI: 10.1177/0300985819891259] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
60 Ji J, Yang H. Using Probiotics as Supplementation for Helicobacter pylori Antibiotic Therapy.Int J Mol Sci. 2020;21. [PMID: 32046317 DOI: 10.3390/ijms21031136] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
61 Nishizuka SS, Tamura G, Nakatochi M, Fukushima N, Ohmori Y, Sumida C, Iwaya T, Takahashi T, Koeda K; Northern Japan Gastric Cancer Study Consortium. Helicobacter pylori infection is associated with favorable outcome in advanced gastric cancer patients treated with S-1 adjuvant chemotherapy. J Surg Oncol 2018;117:947-56. [PMID: 29355977 DOI: 10.1002/jso.24977] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
62 Pasala C, Katari SK, Nalamolu RM, Aparna RB, Amineni U. Integration of core hopping, quantum-mechanics, molecular mechanics coupled binding-energy estimations and dynamic simulations for fragment-based novel therapeutic scaffolds against Helicobacter pylori strains. Computational Biology and Chemistry 2019;83:107126. [DOI: 10.1016/j.compbiolchem.2019.107126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
63 Griffith DM, Li H, Werrett MV, Andrews PC, Sun H. Medicinal chemistry and biomedical applications of bismuth-based compounds and nanoparticles. Chem Soc Rev 2021;50:12037-69. [PMID: 34533144 DOI: 10.1039/d0cs00031k] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Bosques-Padilla FJ, Remes-Troche JM, González-Huezo MS, Pérez-Pérez G, Torres-López J, Abdo-Francis JM, Bielsa-Fernandez MV, Camargo MC, Esquivel-Ayanegui F, Garza-González E, Hernández-Guerrero AI, Herrera-Goepfert R, Huerta-Iga FM, Leal-Herrera Y, Lopéz-Colombo A, Ortiz-Olvera NX, Riquelme-Pérez A, Sampieri CL, Uscanga-Domínguez LF, Velarde-Ruiz Velasco JA. The fourth Mexican consensus on Helicobacter pylori. Rev Gastroenterol Mex (Engl Ed) 2018;83:325-41. [PMID: 29941237 DOI: 10.1016/j.rgmx.2018.05.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Sun X, Bi Y, Nong B, Hu D, Sun X, Chen H, Xu Y, Liu Y. Linked color imaging confers benefits in profiling H. pylori infection in the stomach. Endosc Int Open 2019;7:E885-92. [PMID: 31281873 DOI: 10.1055/a-0895-5377] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
66 Zhang M, Pang M, Zhang M. Efficacy and safety of potassium-competitive acid blockers versus proton pump inhibitors as Helicobacter pylori eradication therapy: a meta-analysis of randomized clinical trials. Clinics (Sao Paulo) 2022;77:100058. [PMID: 35810638 DOI: 10.1016/j.clinsp.2022.100058] [Reference Citation Analysis]
67 Song Z, Chen Y, Lu H, Zeng Z, Wang W, Liu X, Zhang G, Du Q, Xia X, Li C, Jiang S, Wu T, Li P, He S, Zhu Y, Zhang G, Xu J, Li Y, Huo L, Lan C, Miao Y, Jiang H, Chen P, Shi L, Tuo B, Zhang D, Jiang K, Wang J, Yao P, Huang X, Yang S, Wang X, Zhou L. Diagnosis and treatment of Helicobacter pylori infection by physicians in China: A nationwide cross-sectional study. Helicobacter 2022;:e12889. [PMID: 35363917 DOI: 10.1111/hel.12889] [Reference Citation Analysis]
68 Liou JM, Malfertheiner P, Lee YC, Sheu BS, Sugano K, Cheng HC, Yeoh KG, Hsu PI, Goh KL, Mahachai V, Gotoda T, Chang WL, Chen MJ, Chiang TH, Chen CC, Wu CY, Leow AH, Wu JY, Wu DC, Hong TC, Lu H, Yamaoka Y, Megraud F, Chan FKL, Sung JJ, Lin JT, Graham DY, Wu MS, El-Omar EM; Asian Pacific Alliance on Helicobacter and Microbiota (APAHAM). Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut 2020;69:2093-112. [PMID: 33004546 DOI: 10.1136/gutjnl-2020-322368] [Cited by in Crossref: 70] [Cited by in F6Publishing: 52] [Article Influence: 35.0] [Reference Citation Analysis]
69 Karmakar P, Gaitonde V. Promising Recent Strategies with Potential Clinical Translational Value to Combat Antibacterial Resistant Surge. Medicines (Basel) 2019;6:E21. [PMID: 30709019 DOI: 10.3390/medicines6010021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
70 Zhang Y, Chen Y, Lo C, Zhuang J, Angsantikul P, Zhang Q, Wei X, Zhou Z, Obonyo M, Fang RH, Gao W, Zhang L. Inhibition of Pathogen Adhesion by Bacterial Outer Membrane-Coated Nanoparticles. Angew Chem Int Ed Engl 2019;58:11404-8. [PMID: 31206942 DOI: 10.1002/anie.201906280] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 13.3] [Reference Citation Analysis]
71 Daelemans S, Deseck V, Levy EI, Vandenplas Y. Are pro- and/or synbiotics beneficial in Helicobacter pylori eradication therapy in children? A narrative review. Eur J Pediatr 2022. [PMID: 35726032 DOI: 10.1007/s00431-022-04523-7] [Reference Citation Analysis]
72 Keikha M, Karbalaei M. Probiotics as the live microscopic fighters against Helicobacter pylori gastric infections. BMC Gastroenterol 2021;21:388. [PMID: 34670526 DOI: 10.1186/s12876-021-01977-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
73 Wang K, Zhang L, He ZH, Liu ZJ, Zhang L, Hu N, Jin Z, Ke Y, Duan LP. A population-based survey of gastroesophageal reflux disease in a region with high prevalence of esophageal cancer in China. Chin Med J (Engl) 2019;132:1516-23. [PMID: 31045906 DOI: 10.1097/CM9.0000000000000275] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
74 Salillas S, Alías M, Michel V, Mahía A, Lucía A, Rodrigues L, Bueno J, Galano-frutos JJ, De Reuse H, Velázquez-campoy A, Carrodeguas JA, Sostres C, Castillo J, Aínsa JA, Díaz-de-villegas MD, Lanas Á, Touati E, Sancho J. Design, Synthesis, and Efficacy Testing of Nitroethylene- and 7-Nitrobenzoxadiazol-Based Flavodoxin Inhibitors against Helicobacter pylori Drug-Resistant Clinical Strains and in Helicobacter pylori -Infected Mice. J Med Chem 2019;62:6102-15. [DOI: 10.1021/acs.jmedchem.9b00355] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
75 Melese A, Genet C, Zeleke B, Andualem T. Helicobacter pylori infections in Ethiopia; prevalence and associated factors: A systematic review and meta-analysis. BMC Gastroenterol. 2019;19:8. [PMID: 30630433 DOI: 10.1186/s12876-018-0927-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
76 Ramírez-Lázaro MJ, Lario S, Quílez ME, Montserrat A, Bella MR, Junquera F, García-Martínez L, Casalots À, Parra T, Calvet X. Droplet Digital PCR Detects Low-Density Infection in a Significant Proportion of Helicobacter Pylori-Negative Gastric Biopsies of Dyspeptic Patients. Clin Transl Gastroenterol 2020;11:e00184. [PMID: 32568476 DOI: 10.14309/ctg.0000000000000184] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
77 Ismail MB, Osman M, Bou Raad E, Achkar M, Hamze M. Seroprevalence of Helicobacter pylori among dyspeptic patients in northern Lebanon: a 6-year retrospective study in two tertiary hospitals. Access Microbiology 2022;4. [DOI: 10.1099/acmi.0.000337] [Reference Citation Analysis]
78 Liou JM, Lee YC, Wu MS. Treatment of Helicobacter pylori infection and its long-term impacts on gut microbiota. J Gastroenterol Hepatol 2020;35:1107-16. [PMID: 31984532 DOI: 10.1111/jgh.14992] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
79 Klein S, Gildenblat J, Ihle MA, Merkelbach-Bruse S, Noh KW, Peifer M, Quaas A, Büttner R. Deep learning for sensitive detection of Helicobacter Pylori in gastric biopsies. BMC Gastroenterol 2020;20:417. [PMID: 33308189 DOI: 10.1186/s12876-020-01494-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
80 Zhang Y, Chen Y, Lo C, Zhuang J, Angsantikul P, Zhang Q, Wei X, Zhou Z, Obonyo M, Fang RH, Gao W, Zhang L. Inhibition of Pathogen Adhesion by Bacterial Outer Membrane‐Coated Nanoparticles. Angew Chem 2019;131:11526-30. [DOI: 10.1002/ange.201906280] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
81 Chen X, Huang L, Jia Y, Hu R, Gao M, Ren L, Tang BZ. AIE‐Based Theranostic Probe for Sequential Imaging and Killing of Bacteria and Cancer Cells. Adv Optical Mater 2020;8:1902191. [DOI: 10.1002/adom.201902191] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
82 Sasahara GL, Gouveia Júnior FS, Rodrigues RO, Zampieri DS, Fonseca SGDC, Gonçalves RCR, Athaydes BR, Kitagawa RR, Santos FA, Sousa EHS, Nagao-Dias AT, Lopes LGF. Nitro-imidazole-based ruthenium complexes with antioxidant and anti-inflammatory activities. J Inorg Biochem 2020;206:111048. [PMID: 32151873 DOI: 10.1016/j.jinorgbio.2020.111048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Zhang Y, Li H, Wang Q, Hao X, Li H, Sun H, Han L, Zhang Z, Zou Q, Sun X. Rationally Designed Self-Assembling Nanoparticles to Overcome Mucus and Epithelium Transport Barriers for Oral Vaccines against Helicobacter pylori. Adv Funct Mater 2018;28:1802675. [DOI: 10.1002/adfm.201802675] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
84 Ji J, Yang H. In Vitro Effects of Lactobacillus plantarum LN66 and Antibiotics Used Alone or in Combination on Helicobacter pylori Mature Biofilm. Microorganisms 2021;9:424. [PMID: 33670726 DOI: 10.3390/microorganisms9020424] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Chen Z, Chen H, Yu L, Xin H, Kong J, Bai Y, Zeng W, Zhang J, Wu Q, Fan H. Bioinformatic identification of key pathways, hub genes, and microbiota for therapeutic intervention in Helicobacter pylori infection. J Cell Physiol 2021;236:1158-83. [PMID: 32710499 DOI: 10.1002/jcp.29925] [Reference Citation Analysis]
86 Dong SQ, Singh TP, Wei X, Yao H, Wang HL. Review: A Japanese population-based meta-analysis of vonoprazan versus PPI for Helicobacter pylori eradication therapy: Is superiority an illusion? Helicobacter 2017;22:e12438. [DOI: 10.1111/hel.12438] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
87 Wang Y, Guo X, Zhou S, Wang L, Fang Y, Xing L, Zhao Y, Zhang LP, Qiu H, Zeng J, Gu Y. Selective photodynamic inactivation of Helicobacter pylori by a cationic benzylidene cyclopentanone photosensitizer - an in vitro and ex vivo study. J Photochem Photobiol B 2021;223:112287. [PMID: 34454316 DOI: 10.1016/j.jphotobiol.2021.112287] [Reference Citation Analysis]
88 Bornschein J, Pritchard DM. Myths and misconceptions in the management of Helicobacter pylori infection. Frontline Gastroenterol 2022;13:245-53. [DOI: 10.1136/flgastro-2021-101826] [Reference Citation Analysis]
89 Weng CY, Xu JL, Sun SP, Wang KJ, Lv B. Helicobacter pylori eradication: Exploring its impacts on the gastric mucosa. World J Gastroenterol 2021; 27(31): 5152-5170 [PMID: 34497441 DOI: 10.3748/wjg.v27.i31.5152] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]